PinkofView
About
What does PinkofView do?
Pink of View is an Israeli-based medical startup that developed a unique, cloud-based mobile application designed to enable women to identify breast cancer at its early, critical stages. The application supports all major mobile operating systems, including iOS and Android.
What is PinkofView's revenue?
StartupHub estimates PinkofView's annual revenue at $1.1M (range $987K to $2.8M, 68% confidence), based on comparable companies in the sector.
Where is PinkofView headquartered?
PinkofView is headquartered in Tel Aviv, Israel.
When was PinkofView founded?
PinkofView was founded in 2018.
What industry does PinkofView operate in?
PinkofView operates in Healthcare, Risk Analytics, HealthTech, MedTech, Digital Health, Women's Health.
How many employees does PinkofView have?
PinkofView has approximately 6 people on record.
What is PinkofView's current status?
PinkofView's current operating status is: Inactive.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.